"I envision a future where advances in computer intelligence and human health combine"
Will Rosellini is the CEO of Perimeter Medical, Inc and the Chairman of Nexeon Medsystems, Inc., a medical device manufacturing company that went public in 2017. He is a former pitcher with the Arizona Diamondbacks, holds a JD, MBA, MS of Accounting, MS of Computational Biology, MS of Neuroscience, and MS of Regulatory Science.
Perimeter Medical Imaging
Perimeter Medical develops, patents, and commercializes advanced in-procedural medical imaging tools.
The OTIS™ platform provides clinicians with real-time, ultra-high resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen. The ability to visualize microscopic tissue structures during the clinical procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system.
A global medical device company focused on providing innovative neurostimulation products
Nexeon improves the quality of life of patients suffering from debilitating neurological disease.
MicroTransponder Inc. (MTI) has developed the Paired Vagus Nerve Stimulation System (Paired VNS™ System) based on decades of neuroscience research. The Paired VNS™ System has been developed to treat two separate neurological conditions. The first is the Serenity® System for the treatment of chronic tinnitus. The second is the Vivistim® System for treatment of post-stroke upper limb mobility issues.